2019
DOI: 10.21037/atm.2019.04.83
|View full text |Cite
|
Sign up to set email alerts
|

Treatment, complications, and outcomes of metastatic disease of the spine: from Patchell to PROMIS

Abstract: Spinal metastases are common in patients with cancer. As cancer treatments improve and these patients live longer, the number who present with metastatic spine disease will increase. Treatment strategies for these patients continues to evolve. In particular, since the prospective randomized controlled study in 2005 by Patchell et al. showed increased survival with decompressive surgical treatment of spinal metastases, there is a growing body of literature focusing on surgical management and complications of su… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

1
32
0

Year Published

2020
2020
2022
2022

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 45 publications
(37 citation statements)
references
References 72 publications
(115 reference statements)
1
32
0
Order By: Relevance
“…Invaded cancerous cells to spinal column are mostly originates from followings: lungs (31%), breasts (9%), prostate (8%), lymphoma (6%), melanoma (4%), unknown sources (2%), kidneys (1%) and other malignancies including multiple myeloma (3%). In cases of no intervention, poor prognosis expects patients with spinal metastasis [12].…”
Section: Discussionmentioning
confidence: 99%
“…Invaded cancerous cells to spinal column are mostly originates from followings: lungs (31%), breasts (9%), prostate (8%), lymphoma (6%), melanoma (4%), unknown sources (2%), kidneys (1%) and other malignancies including multiple myeloma (3%). In cases of no intervention, poor prognosis expects patients with spinal metastasis [12].…”
Section: Discussionmentioning
confidence: 99%
“…13,19,20 More recent reports have presented lower rates of infection, which may be associated with less invasive techniques. 15,21,22 Due to complications three months after hospital discharge, readmission and reoperation rates ranged from 9.7% to 16.8%, evidencing the impact of the disease and its treatment on the health system. [23][24][25][26] Surgical treatment of spinal metastases carries the same risks as non-oncological surgeries, plus the risk of complicating factors associated with oncological disease and its metastases.…”
Section: Discussionmentioning
confidence: 99%
“…Complications can reduce patients' quality of life, and one of the goals of surgical treatment is to improve this, reinforcing the need for careful evaluation of the indication for surgical treatment. 22 Low albumin levels, additional comorbidities, pathological fractures, involvement of more than three vertebral levels, combined approach, age, type of tumor, blood transfusion and Charlson comorbidity index have all been reported as factors associated with complications of surgical treatment. 21,22 The most frequently reported complication is infection or dehiscence of the surgical wound, which varies from 1.5% to 30% of patients.…”
Section: Discussionmentioning
confidence: 99%
“…Even though studies show that surgery is an important part of the treatment of metastatic spinal tumors, preoperative and/or postoperative radiotherapy is still essential 32 . The timing of radiotherapy should be 1-2 weeks before and after surgery to avoid postoperative complications.…”
Section: Discussionmentioning
confidence: 99%